[Problems of long-term therapy of chronic pyelonephritis].
D000667:Ampicillin / Q000627:therapeutic use; D002228:Carbenicillin / Q000627:therapeutic use; D048909:Diabetes Complications; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D008134:Long-Term Care; D010068:Oxacillin / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use; D011704:Pyelonephritis / Q000188:drug therapy*; D013307:Streptomycin / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013997:Time Factors; D014295:Trimethoprim / Q000627:therapeutic use
D011113:Polymyxins; D013449:Sulfonamides; D007612:Kanamycin; D000667:Ampicillin; D014295:Trimethoprim; D002228:Carbenicillin; D010068:Oxacillin; D013307:Streptomycin
Zur Problematik der Langzeittherapie der chronischen Pyelonephritis.